Cisplatin With or Without Veliparib in Treating Patients With Recurrent or Metastatic Triple-Negative and/or BRCA Mutation-Associated Breast Cancer With or Without Brain Metastases

Clinical trial NCT02595905 · COMPLETED

Trial details

NCT number: NCT02595905
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Metastatic BRCA Hereditary Breast Carcinoma Metastatic Breast Carcinoma Metastatic Malignant Neoplasm in the Brain Metastatic Triple-Negative Breast Carcinoma Recurrent Breast Carcinoma Stage IV Breast Cancer AJCC v6 and v7

Start date: 2016-09-15
Primary completion: 2025-01-01
Enrollment: 344

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.